An insight into Clostridium difficile infection: a single-center retrospective case-control study

Area of Science:

• Infectious Diseases
• Clinical Medicine
• Biomarkers

Background:

• Clostridium difficile infection (CDI) presents a significant global health challenge with substantial medical and economic consequences.
• Existing research has explored CDI risk factors and characteristics, yet further investigation into prognostic indicators is warranted.

Purpose of the Study:

• To characterize risk factors, patient demographics, and outcomes for healthcare facility-acquired CDI (HCFA-CDI) and community-acquired CDI (CA-CDI).
• To identify factors predicting adverse outcomes in CDI patients.
• To evaluate the predictive value of the neutrophil-lymphocyte ratio (NLR) for CDI prognosis.

Main Methods:

• A 3-year retrospective study involving 600 patients, including a control group, HCFA-CDI, and CA-CDI cohorts.
• Analysis of patient characteristics, risk factors, and outcomes associated with CDI.
• Assessment of the neutrophil-lymphocyte ratio (NLR) as a prognostic biomarker.

Main Results:

• An NLR greater than 5 was associated with increased mortality and ICU transfer across all CDI cases by day 2 post-diagnosis.
• In HCFA-CDI, NLR > 5 predicted higher ICU transfer by day 1 and mortality by day 2.
• For CA-CDI, NLR > 5 predicted increased mortality and ICU transfer by day 4 post-diagnosis. Each 10-unit NLR increase correlated with significant increases in mortality and ICU transfer.

Conclusions:

• The neutrophil-lymphocyte ratio (NLR) serves as a valuable and timely predictor of adverse outcomes in CDI patients.
• NLR can effectively forecast intensive care unit (ICU) transfer and mortality risk.
• Early utilization of NLR monitoring can aid in clinical decision-making for CDI management.